Icon ICLR
NASDAQ ICLR
$169.68 -4.26 (-2.45%)
At close: Sep 17, 2026 · 4:00 PM EDT

Icon (ICLR) Income from Non-Controlling Interests (2019 - 2026)

Icon's (ICLR) quarterly Income from Non-Controlling Interests came in at $19.4 million in Q2 2026, up 25.94% year-over-year from $15.4 million in Q2 2025, and down 57.92% quarter-over-quarter from $46.2 million in Q3 2025.

Analysis

Icon (ICLR) Income from Non-Controlling Interests (2019 - 2026) Analysis & Trends

Icon (ICLR) has reported Income from Non-Controlling Interests for 8 consecutive years, with $19.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Income from Non-Controlling Interests rose 25.94% year-over-year to $19.4 million in Q2 2026; TTM through Jun 2026 was $93.4 million, a 105.39% increase from a year earlier, with the FY2024 full-year figure at $45.9 million, down 17.6% from the prior year.
  • Income from Non-Controlling Interests was $19.4 million for Q2 2026 at Icon, down from $46.2 million in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at $46.2 million in Q3 2025 and troughed at $4.7 million in Q4 2024.
  • A 5-year average of $16.5 million and a median of $15.2 million in 2022 frame the typical range for Income from Non-Controlling Interests.
  • Across the five-year window, Income from Non-Controlling Interests plunged 47.86% in 2023 and jumped 254.28% in 2025, its largest moves.
  • Over 5 years, Income from Non-Controlling Interests stood at $15.0 million in 2022, then slumped by 47.86% to $7.8 million in 2023, then tumbled by 40.25% to $4.7 million in 2024, then surged by 885.51% to $46.2 million in 2025, then tumbled by 57.92% to $19.4 million in 2026.
  • The last three Income from Non-Controlling Interests figures came in at $19.4 million (Q2 2026), $46.2 million (Q3 2025), and $15.4 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 2.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn -
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 19.44 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 722,000.00
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -
10 VivoSim Labs 1.37 Mn 1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.44 Mn
Sep 30, 2025 46.19 Mn
Jun 30, 2025 15.43 Mn
Mar 31, 2025 12.29 Mn
Dec 31, 2024 4.69 Mn
Sep 30, 2024 13.04 Mn
Jun 30, 2024 14.96 Mn
Mar 31, 2024 13.18 Mn
Dec 31, 2023 7.85 Mn
Sep 30, 2023 16.47 Mn
Jun 30, 2023 16.60 Mn
Mar 31, 2023 14.76 Mn
Dec 31, 2022 15.05 Mn
Sep 30, 2022 16.73 Mn
Jun 30, 2022 18.89 Mn
Mar 31, 2022 19.22 Mn
Dec 31, 2021 19.41 Mn
Sep 30, 2021 26.36 Mn
Jun 30, 2021 8.80 Mn
Mar 31, 2021 6.84 Mn